Literature DB >> 30825965

Optimal timing of thoracic radiotherapy in limited stage small cell lung cancer (SCLC) with daily fractionation: A brief report.

Shaakir Hasan1, Richard White2, Paul Renz3, Stephen Abel4, Zachary Otaibi5, Dulabh Monga5, Athanasios Colonias4, Rodney E Wegner4.   

Abstract

Survival in limited stage small cell lung cancer (LS-SCLC) improves with faster initiation of hyper-fractionated thoracic radiotherapy (TRT) following chemotherapy, however, it is unknown if this association exists for more commonly employed daily fractionated regimens. Our results suggest that this association is present even with daily fractionation.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Lung cancer; Small cell; Thoracic radiation

Mesh：

Year:  2018        PMID： 30825965     DOI： 10.1016/j.radonc.2018.11.005

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


  5 in total

1.  Pre-radiotherapy lymphocyte count and platelet-to-lymphocyte ratio may improve survival prediction beyond clinical factors in limited stage small cell lung cancer: model development and validation.

Authors:  Yishan Yu; Linlin Wang; Shufen Cao; Siming Gao; Weili Wang; Lianne Mulvihill; Mitchell Machtay; Pingfu Fu; Jinming Yu; Feng-Ming Spring Kong
Journal:  Transl Lung Cancer Res       Date:  2020-12

2.  Optimal timing of radiotherapy in high risk prostate cancer: Do missed days matter?

Authors:  Shaakir Hasan; Daniel Gorovets; Eric Lehrer; Stanislav Lazarev; Robert H Press; Madhur Garg; Keyur J Mehta; Arpit M Chhabra; J Isabelle Choi; Charles B Simone
Journal:  Clin Transl Radiat Oncol       Date:  2020-11-25

3.  One Cycle of Concurrent Chemotherapy vs. Two Cycles of Concurrent Chemotherapy With Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer.

Authors:  Hao Yu; Jiaqi Zhang; Zhen Zhang; Youyou Wang; Guangying Xu; Liming Xu; Ningbo Liu; Lujun Zhao; Ping Wang
Journal:  Front Oncol       Date:  2022-01-24       Impact factor: 6.244

Review 4.  Optimal timing of thoracic irradiation for limited stage small cell lung cancer: Current evidence and future prospects.

Authors:  Omer Sager; Ferrat Dincoglan; Selcuk Demiral; Hakan Gamsiz; Bora Uysal; Fatih Ozcan; Onurhan Colak; Esra Gumustepe; Yelda Elcim; Esin Gundem; Bahar Dirican; Murat Beyzadeoglu
Journal:  World J Clin Oncol       Date:  2022-02-24

5.  Sequential Hypofractionated versus Concurrent Twice-Daily Radiotherapy for Limited-Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis.

Authors:  Wei Zhou; Pang Wang; Xinyu Ti; Yutian Yin; Shigao Huang; Zhi Yang; Jie Li; Guangjin Chai; Bo Lyu; Zhaohui Li; Yan Zhou; Feng Xiao; Lin Xu; Mei Shi; Lina Zhao
Journal:  Cancers (Basel)       Date:  2022-08-13       Impact factor: 6.575
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.